| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/12/2007 | US20070081984 Compositions and methods for treating hypophosphatasia |
| 04/12/2007 | US20070081983 Isolation of smooth muscle cells and tissue-engineered vasculature containing the isolated cells |
| 04/12/2007 | US20070081982 Multiple RNAi expression cassettes for simultaneous delivery of RNAi agents related to heterozygotic expression patterns |
| 04/12/2007 | US20070081981 Expanding population of human hematopoietic stem cells via reduction in activity of cyclin dependent kinases utilizing small RNA interfering; tissue regeneration |
| 04/12/2007 | US20070081978 Adeno-associated virus-mediated survivin mutants and methods related thereto |
| 04/12/2007 | US20070081977 Device for transdermal administration of active substances |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081972 Polymer-based delivery system for immunotherapy of cancer |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | CA2665080A1 Regulatable fusion promoters |
| 04/12/2007 | CA2623818A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | CA2621468A1 Use of recombinant yeast strain producing an anti-inflammatory compound in the manufacture of a medicament to treat colitis |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1772155A1 Medicament for treating avian influenza |
| 04/11/2007 | EP1771570A2 Addition of transgenes into adenoviral vectors |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 04/11/2007 | EP1100825B1 Human mink gene mutations associated with arrhythmia |
| 04/11/2007 | EP1054894B1 Breast cancer resistance protein (bcrp) and the dna which encodes it |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0917585B1 Vectors for delivering viral and oncogenic inhibitors |
| 04/11/2007 | CN1946734A Compositions and methods for the systemic treatment of arthritis |
| 04/11/2007 | CN1946733A RNA-mediated interference to control disease in terrestrial and aquaculture animals |
| 04/11/2007 | CN1946430A Therapeutic agent for treatment of cancer comprising human apolipoprotein (A) kringles LK68 or LK8 genes as effective ingredient, and method for treating cancer using the same |
| 04/11/2007 | CN1946421A Cancer treatment using viruses and camptothecins |
| 04/11/2007 | CN1944655A Recombinant adenovirus of target-oriented coexpressed new p53 and P53AIP1 |
| 04/11/2007 | CN1944647A Dopamine receptor new sub-type D5B gene and coded protein and use |
| 04/11/2007 | CN1943791A Liver target high molecule magnetic resonance image-forming contrast medium and its synthesizing method and application |
| 04/11/2007 | CN1943790A Prevention and treatment of restenosis by local administration of drug |
| 04/11/2007 | CN1943789A The DNA vaccine of an anti-infection of hepatitis C virus |
| 04/11/2007 | CN1943788A The E type DNA vaccine of Chlamydi trachomatis and its preparation methods and applications |
| 04/11/2007 | CN1943782A Medicament for treating avian influenza |
| 04/11/2007 | CN1309833C Angiostatin and its use for preparing medicament |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309739C New fusion protein as carrier |
| 04/11/2007 | CN1309737C Recombinant gelatins |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309392C Hyaluronic acid mediated adenoviral transduction |
| 04/10/2007 | US7202334 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2007 | US7202228 Reaction product of hydrocarbon and nucleotide; heat resistant gel |
| 04/10/2007 | US7202227 Multifunctional molecular complexes for gene transfer to cells |
| 04/10/2007 | US7202226 Augmenting transient protein synthesis in cells in need of increased protein synthesis by increasing protein synthesis from endogenous cellular mRNA in the cells. |
| 04/10/2007 | US7202212 Proteasome mechanisms regulated by PR-39 peptides, selective inhibition of I kappa B alpha degradation on-demand and is used for controlled suppression of NF kappa B transcription factor activity and NF kappa B-dependent gene expression |
| 04/10/2007 | US7202210 Premature peptide for use in treatment of nervous system, muscular, heart, diabetic and bone disorders |
| 04/10/2007 | US7202085 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 04/10/2007 | US7202082 Premature osteoblast cell line derived from the peritoneum of bone for use as models for prevention and treatment of osteoporosis |
| 04/10/2007 | US7202079 Evpression vector for use as tool in genetic engineering |
| 04/10/2007 | US7202078 Composition intended for the preservation of infectious recombinant adenoviruses |
| 04/10/2007 | US7202067 Carotene synthase gene and uses therefor |
| 04/10/2007 | US7202053 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein |
| 04/10/2007 | US7202052 Regulatory protein for use in induction of nicotinamide adenine dinucleotide oxidase (NOX) for use as free radical quencher in prevention and treatment of cardiovascular and cell proliferative disorders |
| 04/10/2007 | US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents |
| 04/10/2007 | US7202025 Control of gene expression |
| 04/10/2007 | US7201908 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | CA2309755C Hormone-dependent forms of the adeno-associated virus, rep proteins, dna sequences coding for them, vectors containing them, and regulatory methods of their intracellular activity |
| 04/10/2007 | CA2242382C Compositions and methods for mediating cell cycle progression |
| 04/10/2007 | CA2209172C Murine monoclonal anti-idiotype antibody 3h1 |
| 04/10/2007 | CA2199131C Retroviral vector hybrids and the use thereof for gene transfer |
| 04/05/2007 | WO2007038249A2 Ultrasonic concentration of carrier particles |
| 04/05/2007 | WO2007038246A2 Solid polymer delivery compositions and methods for use thereof |
| 04/05/2007 | WO2007038241A2 Modulation of mesenchymal and metastatic cell growth |
| 04/05/2007 | WO2007037560A1 Therapeutic or diagnostic application of sgk2 gene |
| 04/05/2007 | WO2007037555A1 Therapeutic or diagnostic application of dusp15 gene |
| 04/05/2007 | WO2007037550A1 Therapeutic or diagnostic application of tsta3 gene |
| 04/05/2007 | WO2007037538A1 Therapeutic or diagnostic application of spo11 gene |
| 04/05/2007 | WO2007037533A1 Therapeutic or diagnostic application of ppp1r3d gene |
| 04/05/2007 | WO2007037532A1 Therapeutic or diagnostic application of srms gene |
| 04/05/2007 | WO2007037514A1 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 04/05/2007 | WO2007037473A1 Method of inhibiting cell migration and cell migration inhibitor |
| 04/05/2007 | WO2007037444A1 Vector for delivering target substance into nucleus or cell |
| 04/05/2007 | WO2007037265A1 Dna vaccine composition |
| 04/05/2007 | WO2007036053A1 Inhibitors of ste20-like kinase (slk) and methods of modulating cell cycle progression and cell motility |
| 04/05/2007 | WO2007036041A1 Sialidase inhibitors for the treatment of cardiovascular disease |
| 04/05/2007 | WO2007036036A1 Method and composition for increasing the engraftment efficiency of stem cells |
| 04/05/2007 | WO2007036028A1 Compositions for and methods of granzyme b inhibition |
| 04/05/2007 | WO2006110689A3 Method of increasing the function of an aav vector |
| 04/05/2007 | WO2006073601A3 Methods and compositions for rna interference |
| 04/05/2007 | WO2005056762A3 Truncated cmv promoters and vectors containing same |
| 04/05/2007 | WO2005000229A3 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 04/05/2007 | US20070078105 Methods and means for obtaining modified phenotypes |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078103 Formulations comprising antisense nucleotides to connexins |
| 04/05/2007 | US20070078102 Bind p50/p65 and/or cRel/p50 heterodimers over p50/p50 homodimers; for inflammatory, immune or autoimmune disease, cancer |
| 04/05/2007 | US20070078101 Regulation of tgf-beta signaling by tomoregulin |
| 04/05/2007 | US20070078088 Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules |
| 04/05/2007 | US20070078085 Methods and compositions for the utilization and targeting of osteomimicry |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077590 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 04/05/2007 | US20070077571 Methods and apparatus for identifying allosterically regulated ribozymes |
| 04/05/2007 | US20070077306 Apatite particle, method of producing the same, apatite particle-gene complex, and method of gene transfection |
| 04/05/2007 | US20070077291 Drug delivery nanocarriers targeted by landscape phage |
| 04/05/2007 | US20070077272 Solid polymer delivery compositions and methods for use thereof |
| 04/05/2007 | US20070077266 Drug/gene eluting stent |
| 04/05/2007 | US20070077250 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 04/05/2007 | US20070077244 Inhibitor protein of the wnt signal pathway |
| 04/05/2007 | US20070077239 Peptide carrier for drug delivery |
| 04/05/2007 | US20070077234 Regulation of T cell-mediated immunity by tryptophan |
| 04/05/2007 | US20070077233 Inhibition of pathological angiogenesis in vivo |